62 related articles for article (PubMed ID: 18290850)
1. Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients.
Shimomura T; Anan F; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H; Fujiki M; Kobayashi H
Eur J Neurol; 2008 Mar; 15(3):289-94. PubMed ID: 18290850
[TBL] [Abstract][Full Text] [Related]
2. The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients.
Anan F; Masaki T; Iwao T; Eto T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
Curr Med Res Opin; 2008 Jun; 24(6):1561-7. PubMed ID: 18423105
[TBL] [Abstract][Full Text] [Related]
3. Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients.
Anan F; Masaki T; Kikuchi H; Iwao T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
Diabetes Res Clin Pract; 2010 Feb; 87(2):233-9. PubMed ID: 19931932
[TBL] [Abstract][Full Text] [Related]
4. The role of homocysteine as a significant risk factor for white matter lesions in Japanese women with rheumatoid arthritis.
Anan F; Masaki T; Tatsukawa H; Nagano S; Oribe M; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2009 Jan; 58(1):69-73. PubMed ID: 19059533
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients.
Anan F; Masaki T; Jikumaru K; Iwao T; Eshima N; Saikawa T; Yoshimatsu H
Eur J Clin Invest; 2010 Jul; 40(7):585-90. PubMed ID: 20497462
[TBL] [Abstract][Full Text] [Related]
6. Visceral fat accumulation is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients.
Anan F; Masaki T; Eto T; Iwao T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
Eur J Clin Invest; 2009 May; 39(5):368-74. PubMed ID: 19320939
[TBL] [Abstract][Full Text] [Related]
7. Correlations between homocysteine levels and atherosclerosis in Japanese type 2 diabetic patients.
Anan F; Masaki T; Umeno Y; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2007 Oct; 56(10):1390-5. PubMed ID: 17884450
[TBL] [Abstract][Full Text] [Related]
8. Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients.
Anan F; Masaki T; Ito Y; Eto T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2010 Mar; 59(3):314-9. PubMed ID: 20004426
[TBL] [Abstract][Full Text] [Related]
9. White matter lesions are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetes mellitus patients.
Anan F; Masaki T; Shinohara T; Yufu K; Takahashi N; Nakagawa M; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2009 May; 58(5):696-703. PubMed ID: 19375594
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance.
Buysschaert M; Dramais AS; Wallemacq PE; Hermans MP
Diabetes Care; 2000 Dec; 23(12):1816-22. PubMed ID: 11128359
[TBL] [Abstract][Full Text] [Related]
12. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
13. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
[TBL] [Abstract][Full Text] [Related]
14. Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
Anan F; Takahashi N; Shinohara T; Nakagawa M; Masaki T; Katsuragi I; Tanaka K; Kakuma T; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Eur J Clin Invest; 2006 Jul; 36(7):459-65. PubMed ID: 16796602
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.
Anan F; Yonemochi H; Masaki T; Takahashi N; Nakagawa M; Eshima N; Saikawa T; Yoshimatsu H
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):28-35. PubMed ID: 16896659
[TBL] [Abstract][Full Text] [Related]
16. [Changes of plasma total homocysteine in type I diabetic patients its association with diabetic vascular complications].
Yu TT; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):980-4. PubMed ID: 19253841
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis.
Anan F; Takahashi N; Shimomura T; Imagawa M; Yufu K; Nawata T; Nakagawa M; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2006 May; 55(5):656-61. PubMed ID: 16631443
[TBL] [Abstract][Full Text] [Related]
19. [The impact of plasma homocysteine level on development of retinopathy in type 2 diabetes mellitus].
Yang G; Lu J; Pan C
Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):34-8. PubMed ID: 11940295
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity C-reactive protein is associated with hippocampus volume in nondementia patients with type 2 diabetes mellitus.
Anan F; Masaki T; Shimomura T; Fujiki M; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2011 Apr; 60(4):460-6. PubMed ID: 20537668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
